HKSE - Delayed Quote HKD

Beauty Farm Medical and Health Industry Inc. (2373.HK)

Compare
17.080 -0.120 (-0.70%)
As of 3:07 PM GMT+8. Market Open.
Loading Chart for 2373.HK
DELL
  • Previous Close 17.200
  • Open 17.200
  • Bid 17.020 x --
  • Ask 17.080 x --
  • Day's Range 17.080 - 17.280
  • 52 Week Range 9.380 - 17.580
  • Volume 37,000
  • Avg. Volume 78,682
  • Market Cap (intraday) 4.027B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 16.75
  • EPS (TTM) 1.020
  • Earnings Date --
  • Forward Dividend & Yield 0.47 (2.73%)
  • Ex-Dividend Date Jul 2, 2024
  • 1y Target Est 17.44

Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, such as energy-based services and injection services, as well as surgical aesthetic medical services; and subhealth assessment and intervention services. As of June 30, 2022, the company operated 352 stores, including 177 direct stores and 175 franchised stores under the BeautyFarm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

www.beautyfarm.com.cn

3,925

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2373.HK

View More

Performance Overview: 2373.HK

Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2373.HK
58.79%
HANG SENG INDEX
13.54%

1-Year Return

2373.HK
38.10%
HANG SENG INDEX
10.45%

3-Year Return

2373.HK
44.00%
HANG SENG INDEX
19.62%

5-Year Return

2373.HK
44.00%
HANG SENG INDEX
28.19%

Compare To: 2373.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2373.HK

View More

Valuation Measures

Annual
As of 11/27/2024
  • Market Cap

    4.06B

  • Enterprise Value

    3.02B

  • Trailing P/E

    16.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.64

  • Price/Book (mrq)

    4.55

  • Enterprise Value/Revenue

    1.25

  • Enterprise Value/EBITDA

    8.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.76%

  • Return on Assets (ttm)

    5.30%

  • Return on Equity (ttm)

    29.18%

  • Revenue (ttm)

    2.25B

  • Net Income Avi to Common (ttm)

    219.25M

  • Diluted EPS (ttm)

    1.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.57B

  • Total Debt/Equity (mrq)

    69.05%

  • Levered Free Cash Flow (ttm)

    338.81M

Research Analysis: 2373.HK

View More

Company Insights: 2373.HK

Research Reports: 2373.HK

View More

People Also Watch